Jefferies Lifts Est./PT on Abbott Labs (ABT) after In-Line Q1

April 19, 2013 8:28 AM

Jefferies raised estimates and its price target on Abbott Labs (NYSE: ABT) from $42 to $43 following Q1 results.

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found